Literature DB >> 21112460

Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol.

Amir I A Ahmed1, Patricia van Mierlo, Paul Jansen.   

Abstract

In the Netherlands, the prescription of beta-blockers to patients older than 70 years has increased sharply in recent years. The neuropsychiatric adverse reactions associated with the use of beta-blockers are relatively uncommon and they are mostly seen with poisoning or overdose. We describe an 81-year-old man who developed sleep disorders, nightmares, depression and anxiety as probable adverse effect of low-dose metoprolol (25 mg/day). This case illustrates not only the neuropsychiatric adverse reactions of beta-blockers, but also that diagnosis of these reactions can be easily missed in elderly patients.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112460     DOI: 10.1016/j.genhosppsych.2010.04.008

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  4 in total

1.  Pharmacological Management of Anxiety Disorders in the Elderly.

Authors:  Elizabeth A Crocco; Sindy Jaramillo; Caroline Cruz-Ortiz; Katherine Camfield
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-10

2.  Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders.

Authors:  Xuelu Liu; Xueming Lou; Xianliang Cheng; Yong Meng
Journal:  Drug Des Devel Ther       Date:  2017-01-25       Impact factor: 4.162

3.  Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study.

Authors:  XiaoLiang Cheng; Min Zhu; Qing Liu; Zhenxia Feng; Yong Meng
Journal:  Drug Des Devel Ther       Date:  2020-08-25       Impact factor: 4.162

4.  Improvement in quality of life of Chinese chronic heart failure patients with neuropsychiatric complications over 12-months post-treatment with metoprolol.

Authors:  Ran Zhang; Jingjing Huang; Qiuhong Shu; Liyong Wu; Qian Zhang; Yong Meng
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.